THCA is the most abundant of all the cannabinoids, with a unique compound that's non-psychoactive and medically beneficial.
Research suggests CBGV playsa key role in helping CBD attach to the body’s receptors once ingested, increasing the overall benefits of medicinal marijuana.
Unlike most cannabinoids, cannabinol (CBN) rarely results from the decarboxylation of its acid form (CBNA) and performs similarly to THC.
What sets THCV apart from the other cannabinoids is it has the ability to suppress appetite, as studies are demonstrating.
We spoke exclusively to Ethan Russo who believes that many common diseases stem from clinical endocannabinoid deficiency.
Beta-Caryophyllene is a rare terpene as it is one of the first non-cannabinoids to directly activate cannabinoid receptors.
Nate Pennington from Humboldt Seed Company talks us through the newest weed strains that we're excited to see hit the market in 2019.
The Honest Marijuana Company is currently working on a nano-cannabinoid technology that will deliver cannabinoids in a time-released fashion.
The little research available suggests that some parts of cannabis may be more helpful than others for treating chronic kidney disease.
Nathaniel Pennington from Humboldt Seed Company explains his phenotype mega-hunt — the search for the best and brightest of the cannabis genome.